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Gastric adenoma is a precancerous lesion of the stom-
ach and its malignant transformation is thought to
result from accumulative series of gene alterations.
The aim of this study was to determine the pattern of
chromosomal changes during gastric carcinogenesis.
Pairs of adenoma and carcinoma tissues from 15 gas-
trectomy cases containing both adenomas and carci-
nomas in the same (adjacent pairs, 6 cases) and dif-
ferent (non-adjacent pairs, 9 cases) lesions, were
analyzed for chromosomal alterations of 39 non-ac-
rocentric chromosomal arms by comparative
genomic hybridization (CGH). CGH analysis identi-
fied frequent chromosomal alterations in most of the
gastric adenomas (14/15, 93%) and all of the carcino-
mas. The mean number of chromosomal alterations
was higher in carcinoma (5.5 for adenoma and 11.7
for carcinoma; P 5 0.006, by nonparametric Wilcox-
on’s test). Losses on the short arm of chromosome 17
were most common in both adenomas (43%) and
carcinomas (67%). The pattern of chromosomal alter-
ations in paired gastric adenomas and carcinomas
showed greater similarity compared to the non-case
pairs and this similarity was increased in the adjacent
pairs. Deletion mapping analysis on chromosome
17p also demonstrated that the conserved deletion
area was more frequent in the adjacent pairs. Among
these 6 adjacent pairs, all had common deletion ar-
eas. In contrast, among the 9 non-adjacent pairs, 2
(22%) had common area of deletion, 5 (56%) showed
deletion only in the carcinoma, and the remaining 2
(22%) had no deletion on 17p, suggesting diverse
genetic changes might be involved in the multiple
tumor formation. Our results that common clonal
genetic changes between adjacent pairs of gastric ad-
enomas and carcinomas and accumulated genetic
changes in the carcinomas provide evidences for the
stepwise mode of gastric carcinogenesis through the
accumulation of a series of genetic alterations. (Am J
Pathol 2001, 158:655–662)
Accumulated evidence has established that carcinogen-
esis is a multistep process that is associated with alter-
ations in cellular oncogenes and tumor suppressor genes
necessary for malignant transformation.1,2 Two main ge-
netic pathways appear to be involved in gastrointestinal
tumors; genomic instability associated with multiple chro-
mosomal alterations, and genomic instability associated
with defective DNA mismatch repair in tumors, which is
called microsatellite instability (MSI).1,3,4 Gastric carcino-
genesis also displays multiple genetic alterations includ-
ing oncogenes, tumor suppressor genes, and DNA mis-
match repair genes.5–11 The results of molecular genetic
changes related to gastric carcinomas have recently
been rapidly accumulating. DNA aneuploidy, proto-on-
cogene activation, tumor suppressor gene inactivation,
and defective DNA mismatch repair genes have been
reported in gastric carcinomas. The change in DNA copy
numbers is one of the hallmarks of the gastric carcino-
genesis and is considered to be related to oncogene
activation and tumor suppressor gene inactivation. Al-
though many chromosomal aberrations have been re-
ported in gastric carcinogenesis, there remains disagree-
ments among the previous studies. Frequent nonrandom
chromosomal deletions on 1q, 5q, 7q, 9p, 11p, 11q, 13q,
16q, 17p, and 18q were observed in gastric carcino-
mas.5,12–17 In addition, recent studies with comparative
genomic hybridization (CGH) analysis have demon-
strated that chromosomal gains are also frequent in gas-
tric carcinomas.18–23 These chromosomal gains are
found in various combinations with chromosomal losses
and may be associated with the overexpression of dom-
inant oncogenes contributing to tumor progression.
Gastric adenoma is a precancerous lesion of the stom-
ach and is associated with intestinal type carcinoma. The
adenoma-carcinoma sequence in gastric carcinogenesis
is believed to exist in a subset of gastric carcinomas and
might develop through accumulative series of genetic
alterations similar to that of colorectal cancer.24,25 Inac-
tivation of p53 has been reported in gastric adeno-
mas.26,27 In addition, microsatellite instability (MSI) was
reported in a subset of gastric adenomas.24,28 Little is
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known, however, about the pattern of genetic changes
during the progression through the gastric adenoma-
carcinoma sequence, because only small numbers of
adenomas have been studied, and conflicting results
have been reported.20,29,30 We had previously demon-
strated the possible sequence of genetic events in gas-
tric adenomas with MSI,31 and found that the frequency
of MSI in gastric adenomas was similar to that of gastric
carcinomas, but frameshift mutations of the target genes
were not frequent. The genetic pathways of microsatellite
stable gastric adenomas, which account for more than
80% of sporadic tumors, have not been elucidated.
To address these uncertainties about genetic charac-
teristics in the gastric adenoma-carcinoma sequence, we
studied the chromosomal alterations in paired adenoma
and carcinoma tissues from 15 gastrectomy cases. We
evaluated the chromosomal copy number changes by
CGH analysis. We also compared the adenomas and
carcinomas for the frequency and extent of the chromo-
somal deletions by deletion mapping study on the short
arm of chromosome 17. The results have implications for
the understanding of the biology of gastric neoplasia as
well as diagnosis and treatment.
Materials and Methods
Tissue Samples
Pairs of adenoma and carcinoma tissues from 15 gas-
trectomy cases were included in this study. All cases had
synchronous adenoma and carcinoma, which were iden-
tified prospectively and consecutively among 626 cases
of gastric carcinomas in the Department of Pathology at
Yonsei University Medical Center (Seoul, Korea) between
September 1995 and November 1999 for a study of mo-
lecular markers in gastric carcinomas. Among the 15
adenomas, 6 were present in the periphery of the carci-
nomas (adjacent pairs, Figure 1) and 9 were present in
separate lesions (non-adjacent pairs, Figure 2). Informa-
tion from chart reviews and clinicians was obtained to
determine demographic data and tumor sites. The pa-
tients included were 3 females and 12 males, ranging in
age from 51 to 82 years.
For DNA extraction, tumors and adjacent nontumorous
mucosal tissues were obtained immediately after surgical
excision. The selected tissues were rapidly frozen in liq-
uid nitrogen and stored at 270°C until the DNA was
isolated. To enrich the tumor cell population, areas con-
taining more than 80% of tumor cells were selected from
the hematoxylin-eosin (H&E)-stained slides using a cryo-
stat microdissection technique. Genomic DNA was pre-
pared by the sodium dodecyl sulfate-proteinase K and
phenol-chloroform extraction method.
Pathological Analysis
Conventional pathological parameters (tumor size, tumor
number, and differentiation) were examined prospec-
tively without knowledge of the molecular data. The gas-
tric adenomas were divided into two groups (low grade
and high grade dysplasia), according to the criteria of
Lewin.32 Using these criteria, 6 cases were categorized
as low grade dysplasia and 9 cases as high grade dys-
plasia. Gastric carcinomas were classified according to
the Lauren’s classification; all cases were categorized as
intestinal type.33
Figure 1. Examples of synchronous gastric adenoma and carcinoma in the
same lesion (adjacent pair). Gross features of a tumor in the body (A) and
schematic histological figure of mapping; gray box denotes adenoma and
black box denotes carcinoma (B). Light microscopic findings of adenoma
and carcinoma (C).
Figure 2. Examples of synchronous gastric adenoma and carcinoma in the
different lesion (non-adjacent pair). Gross features of a flat adenoma (white
arrow) in the distal antrum and ulcerating carcinoma in the body (A). Light
microscopic findings of adenoma (B) and carcinoma (C).
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Comparative Genomic Hybridization and Digital
Image Analysis
Genomic DNA samples from tumors were labeled with
Spectrum Green dUTP (Vysis Inc., Downers Grove, IL),
and normal reference genomic DNA was labeled with
Spectrum Red dUTP (Vysis) using the nick translation
technique. Labeled tumor and reference DNA (200–400
ng), as well as 10 mg of unlabeled human Cot-1 DNA
(Vysis) were dissolved in 10 ml of hybridization buffer
(50% formamide, 10% dextran sulfate, and 23 SSC) and
denatured at 72°C for 2 minutes. Hybridization was per-
formed at 37°C on denatured normal metaphase
spreads. After hybridization for 3 days, the slides were
washed and counterstained with 49,6-diamidino-2-phe-
nylindole dihydrochloride (DAPI) in antifade solution.
CGH hybridizations were analyzed using an Olympus
fluorescent microscope and the Cytovision image analy-
sis system (Applied Imaging, Sunderland, Tyne & Wear,
UK). Three digital images (DAPI, Spectrum Green, and
Spectrum Red) were acquired from 10 to 20 metaphases
in each hybridization. Normal male DNA and DNA from
tumor cell lines with known aberrations were used as
control test DNA. Green-to-red intensity ratio profiles
were calculated for each chromosome and threshold
values defining gains and losses were set at 1.25 and
0.75, respectively. High level increase in copy number
(amplicon) was defined as ratio of tumor/reference
greater than 1.5.
Deletion Mapping on the Chromosomal
Arm of 17p
Fifteen pairs of DNA from gastric adenomas and car-
cinomas and matched normal DNAs were PCR ampli-
fied at 9 microsatellite loci of 17p (D17S786, D17S796,
D17S921, D17S947, D17S969, D17S1871, D17S1879,
D17S20 14, and D17S2027) to evaluate the frequency
and extent of the deletion area. PCR reactions were
carried out in a mixture of 20 ml containing 1.5 mmol/L
MgCl 2, 20 pmol primer, 0.2 mmol/L each dATP, dGTP,
and dTTP, 5 mmol/L dCTP, 1 mCi of [a-32P]dCTP (3000
Ci/mmol; NEN DuPont, Boston, MA), 50 ng of sample
DNA, 13 PCR buffer, and 1.25 U Taq polymerase
(Gibco-BRL, Grand Island, NY). After denaturation at
95°C for 5 minutes, DNA amplification was performed
in 25 cycles consisting of denaturation at 95°C for 30
seconds, primer annealing at 55– 60°C for 30 seconds,
and elongation at 72°C for 15 seconds. PCR products
were separated in 6% polyacrylamide gel containing
5.6 mol/L urea, followed by autoradiography. Allelic
deletion was scored when the band intensity of one
marker was significantly decreased (.70% reduction)
in tumor DNA compared with that in normal DNA. MSI
was determined by the mobility shift of products from
PCR. In tumors with MSI, additional bands were found
in the normal allele regions.
Statistical Analysis
Differences in DNA copy number aberrations between
the adenomas and carcinomas were compared using the
Wilcoxon’s signed rank test and Fisher’s exact test by
contingency table analysis. For the evaluation of nonran-
dom similarities between adenomas and carcinomas,
summary statistical analysis was performed to compare
the gains and losses among pairs of tumors, at each of
the chromosome arms as described previously. 34 Com-
parisons were performed on two types of pairs: (i) adja-
cent pairs of adenomas and carcinomas, and (ii) non-
adjacent pairs of adenomas and carcinomas.
Results
Chromosomal Copy Number Aberrations in
Gastric Adenomas by CGH Analysis
Chromosomal alterations were found in 14 cases (93%)
among the 15 gastric adenomas: 7 cases showed both
chromosomal losses and gains, 5 cases showed only
chromosomal losses, and the remaining 2 cases showed
only chromosomal gains. A schematic summary of all
chromosomal copy number aberrations is shown in Table
1 and Figure 3. The chromosomal losses were more
frequent than the gains. The mean number of chromo-
somal losses was 3.7 and of gains, 1.9. Frequent chro-
mosomal losses (.40%) were detected in 17p (47%).
Several other chromosomal arms also showed segmental
losses or gains as presented in the Figure 4A.
Chromosomal Copy Number Aberrations in
Gastric Carcinomas by CGH Analysis
All of the 15 gastric carcinomas showed both chromo-
somal losses and gains for at least one of the chromo-
somal arms and all of the 39 evaluated chromosomal
arms showed chromosomal aberrations for at least 1
patient. The mean number of chromosomal losses was
6.7 and for the gains was 4.9. The mean number of
chromosomal alterations was not related to the tumor
stage: 19 in stages I and II, 14.5 in stages III and IV (P 5
0.33). A schematic summary of copy number aberrations
is shown in Table 1 and Figure 3. The chromosomal arms
with frequent losses (.40%) were 12q (40%), 14q (53%),
15q (40%), 16p (40%), and 17p (67%). Chromosomal
gains were also frequent, and were observed in 8q
(80%), 13q (40%), and 20p (40%). Most of the chromo-
somal gains on 8q showed a wide scope of alterations
usually covering the entire chromosomal arm, whereas
gains of the other chromosomal arms usually involved
small segmental areas (Figure 4B). In contrast to the
gastric adenomas, several amplicons were present in
gastric carcinomas. Among the chromosomal arms with
gains, amplicons were present in 8q (3 cases), 20p and
20q (2 cases), and 8p, 13q, and 15q (1 case), as shown
in Figure 4B.
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Comparison of Chromosomal Aberrations in
Gastric Adenomas and Carcinomas
In our gastric adenomas and carcinomas, both tumors
showed gains and losses on several chromosomal arms.
The number of chromosomal alterations, however, was
significantly higher in carcinomas and the mean number
of chromosomal alterations was 5.5 in adenoma and 11.7
in carcinoma (P 5 0.006). When the chromosomal alter-
ations of gastric adenomas and carcinomas were com-
pared within case pairs, common alterations were found.
All of the 14 gastric adenomas with chromosomal alter-
ations had common chromosomal changes with the
paired carcinomas in more than one chromosomal arm.
Additional analysis was performed using summary statis-
tics,34 which was applied to the adjacent and non-adja-
cent type pairs of tumors. The distributions of these pair-
ings are shown in Figure 5. These plots showed that when
the pairs were from the same patient, the summary sta-
tistics were greater than when the pairs were from differ-
ent patient. In our gastric adenomas and carcinomas, the
chromosomal changes within the case pairs showed
greater similarities than between the non-case pairs.
These similarities were more significant in adjacent pairs
of gastric adenomas and carcinomas: similarities were
found in all of the adjacent pairs and only in some of the
non-adjacent pairs (Figure 5).
Deletion Mapping on the Chromosomal
Arm of 17p
A deletion mapping study on the short arm of chromo-
some 17 by using 9 microsatellite markers was carried
out in 15 cases of paired gastric adenomas and carcino-
mas. For each case, genomic DNAs from the tumor and
matched normal tissue were analyzed by polymerase
chain reaction based loss of heterozygosity (PCR-LOH)
method. Representative PCR-LOH results are shown in
Table 1. Summary of Pathological Data and DNA Copy Number Changes in 15 Paired Gastric Adenomas and Carcinomas
Case
no.
Location of
adenoma and
carcinoma
Adenoma
Tumor
stage‡
Carcinoma
DNA copy
number over-
representations
DNA copy
number under-
representations
DNA copy
number over-
representations
DNA copy
number under-
representations
1 adjacent* 6q, 13q 1p, 2p, 2q, 4p, 4q,
10q, 11q, 12q, 14q,
15q, 16p, 17p, 17q,
20q
I 5p, 6q, 7p, 7q, 8q, 13q 1p, 2p, 2q, 4p, 4q, 11q, 12q,
14q, 15q, 16p, 17p, 17q,
20p, 20q
2 adjacent 8q, 12q, 13q 1p, 15q, 16p, 17p I 4q, 8q, 12q, 13q 1p, 9q, 11q, 14q, 15q, 16p,
16q, 17p, 19p, 19q
3 adjacent No change No change I 8q 14q
4 adjacent 2q, 3q, 6q, 7q,
8q, 13q, 14q,
20p
4p, 6p, 12q, 14q, 16p,
17p
I 2q, 3q, 6q, 7q, 8p, 8q,
13q, 20p
4p, 4q, 9q, 12q, 14q, 16p,
17p, 17q, 18p, 18q
5 adjacent 3q 13q, 17p, 18q I 3q, 6q, 8q, 10p, 11p,
17q, 20p
13q, 15q, 17p, 18q
6 adjacent No change 4q, 6p, 17p, 17q I 8q 4q, 6p, 13q, 17p, 17q
7 non-adjacent† 11q, 13q, 18q 1p, 9q, 12q, 15q, 20q III 11q, 12p, 13q 1p, 2p, 2q, 3q, 6q, 12q, 15q
8 non-adjacent 20p 8q, 11q I 1p, 2p, 2q, 3p, 3q, 5p,
6p, 7p, 8q, 10q,
11p, 15q, 20p, 20q
4p, 5q, 8p, 9p, 11q, 16p,
17p, 18p, 18q
9 non-adjacent No change 1p, 9q, 11q, 15q, 16p,
16q, 17p
III 1q, 2q, 7p, 8q 1p, 4p, 9q, 11q, 12q, 14q,
15q, 16p, 17p, 17q, 21q,
22q
10 non-adjacent 8q No change II 1q, 3q, 5p, 6p, 7p, 7q,
8q, 10p, 13q, 16p,
18q, 20p, 20q
3p, 4p, 4q, 5q, 6q, 9p, 14q
11 non-adjacent 3q, 8p, 12q,
19p, 19q, 20p
18p IV 3q, 8p, 13q, 19p, 19q,
20p
17p
12 non-adjacent No change 10q, 12q, 16p, 17p III 8p, 8q 3p, 12q, 14q, 17p
13 non-adjacent 4q, 8p, 8q No change III 4q, 8p, 8q 9q
14 non-adjacent No change 9p, 20p, 20q III 5p, 8q, 20p 1p, 4q, 9p, 14q, 15q, 16p,
16q, 17p, 18q
15 non-adjacent No change 10p, 11p II No change 2q, 8p, 11p, 11q, 12q, 22q
*Adjacent denotes paired adenoma and carcinoma in the same lesion.
†Non-adjacent denotes paired adenoma and carcinoma in the different lesion.
‡UICC tumor staging classification.48
Figure 3. The rate of chromosomal loss and gain observed on a designated
39 non-acrocentric chromosomal arms of paired gastric adenomas and car-
cinomas in graphic form. Each bar represents the percentage of loss (lower)
or gain (upper) of a chromosomal arm; the white bar represents adenoma
and the black bar represents carcinoma.
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Figure 6. Among the 15 pairs of gastric adenomas and
carcinomas, 3 adenomas (cases 9, 12, and 13) and 2
carcinomas (cases 13 and 15) showed MSI on multiple
loci and these cases were also categorized as high MSI
(MSI-H) with the 5 markers proposed by the National
Cancer Institute.35 The overall LOH on 17p was 8 in
adenomas and 13 in carcinomas. Among the 8 adeno-
mas and 13 carcinomas with 17p deletion, 4 (50%) ade-
nomas and 7 carcinomas (54%) showed LOH in most of
the foci, suggesting entire deletion on the short arm of the
chromosome 17, whereas the remaining 4 adenomas
(50%) and 6 carcinomas (46%) showed partial LOH.
Detailed deletion mapping identified two independent
commonly deleted regions on chromosome 17p. The first
region was between D17S2014 and D17S796, encom-
passing approximately 8cM region and defined by
D17S2027 locus. The second region could be defined by
the D17S947, D17S921, and D17S1871 locus. Compari-
son of the deletion area between adenomas and carci-
nomas on chromosome 17p demonstrated carcinoma as
having a wider area of deletion, and the conserved de-
letion area was more frequent in the adjacent pairs of
adenomas and carcinomas. Among the 6 pairs of adja-
cent adenomas and carcinomas, all had common dele-
tion areas. In contrast, of the 9 non-adjacent pairs of
gastric adenomas and carcinomas, 2 (22%) had com-
mon areas of deletion, 5 (56%) showed deletion only in
the carcinoma, and the remaining 2 (22%) had no dele-
tion on 17p (Figure 6).
Discussion
In this study, pairs of gastric adenoma and carcinoma
were investigated for chromosomal abnormality. We
demonstrated more frequent chromosomal losses and
gains in gastric carcinomas than the adenomas. We also
demonstrated the pattern of chromosomal alterations in
paired adenomas and carcinomas showed great similar-
ity than the non-case pairs, and this similarity was more
prominent in the adjacent pairs than the non-adjacent
pairs.
Figure 4. Summary of CGH imbalance detected in 15 paired gastric adenomas (A) and carcinomas (B). Vertical lines on the left of each chromosome idiogram
represent chromosomal losses, whereas vertical lines on the right correspond to chromosomal gains. Amplicon is demonstrated as thick vertical lines on right.
Figure 5. Distribution of summary statistic for adenoma-carcinoma pairs. M,
pairs from the different patient; f, pairs from the same patient within the
same lesion (adjacent pair); o, pairs from same patient in the different lesion
(non-adjacent pair). S value was used to evaluate the similarity between the
adjacent and non-adjacent pairs of adenomas and carcinomas. Briefly, S
value was defined as positive when the same chromosomal changes were
present in the paired adenomas and carcinomas. In contrast, it was defined
as negative when different chromosomal changes were present in the paired
lesion. The S value was scored higher when the chromosomal changes of low
frequency was observed simultaneously in the paired lesion. In contrast, the
chromosomal changes of high frequency were given the lower score. Higher
S values (similarities) were observed within case pairs. Closer similarities
were observed in the adjacent pairs.
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The frequent LOH of the several chromosomal arms in
gastric carcinomas, which have previously been reported
imply the presence of tumor suppressor genes. Many
segments of chromosomal arms had been reported to
have frequent losses.5,10,12–17,30,36 Among these chro-
mosomal arms, losses on 17p, 3q, and 5q are known to
be associated with specific target gene inactivation. Loss
of 17p is known to be associated with p53 inactivation by
either mutation or deletion,5,10,37 FHIT gene inactivation
with 3p deletion,38 and APC gene deletion on 5q39 in
gastric carcinomas have been reported. In this study we
demonstrated deletion of chromosome 17p as a frequent
and early genetic event in gastric carcinogenesis. In our
cases, the common deletion area on chromosome 17p
encompasses the p53 locus, suggesting p53 alteration
as an early genetic event in gastric carcinogenesis. Sev-
eral common deletion areas on chromosome 1p,40
6q,41,42 7q,14,43 11,17 and 16q16 have been identified in
gastric carcinomas by fine deletion mapping analysis.
However, no gastric carcinoma-related specific tumor
suppressor gene has been identified so far in these chro-
mosomal areas.
We also found frequent chromosomal gains on 8q,
13q, and 20p by CGH analysis. Recent chromosomal
copy number analysis of gastric carcinoma by CGH has
reported frequent gains on the several chromosomal
arms,18–20,44 which had not been reported in earlier stud-
ies on the changes of DNA copy number by PCR-LOH
analysis. The PCR-LOH study is useful in identifying small
interstitial deletions, because the microsatellite markers
are highly polymorphic and evenly distributed on the
chromosomes.45 However, it is impossible to differentiate
between chromosomal gains and losses in many cases.
This problem can be resolved by CGH or arbitrarily
primed PCR fingerprinting analysis, which can differenti-
ate between chromosomal gains and losses.46 Of the 3
chromosomal arms with frequent gains in this study, we
detected the gains of 8q and 13q by arbitrarily primed
PCR fingerprinting analysis (data not shown) by using
two primers, BLUE and MCG1. We could not, however,
confirm the chromosomal gains of 20p because no cor-
responding band for the chromosomal arm of 20p was
present with these two primers. Our findings, together
with those of previous studies, support the hypothesis
that chromosomal gains associated with specific onco-
gene activation are also important in gastric carcinogen-
esis.
Our evaluation of chromosomal alterations in gastric
carcinomas permitted the identification of the striking
intertumoral heterogeneity of chromosomal losses and
Figure 6. A: Schematic representation of LOH in paired gastric adenomas and carcinomas with 9 microsatellite markers mapped from D17S2014 to D17S1871. The
markers are listed in relative positions from centromeric to the most telomeric locus at intervals of approximately 4cM. The conserved deletion area were frequent
in the adjacent pairs of gastric adenomas and carcinomas (cases 1–6), whereas different deletion patterns were observed in the non-adjacent pairs of adenomas
and carcinomas (cases 7–12 and 14). M, retention of heterozygosity; f, allelic loss; o, microsatellite instability; c, not informative. B: Representive autoradiographs
of loss of heterozygosity (LOH) by D17S921 marker. The adenoma (A), carcinoma (C), and corresponding non-tumorous tissue (N) are shown with D17S921
marker indicated at the left. Cases 2, 4, and 5 showed losses in both adenoma and carcinoma, whereas case 14 showed loss only in carcinoma. Case 9 also showed
microsatellite instability phenotype in adenoma.
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gains. Gastric carcinomas are not a homogenous dis-
ease and different patterns of genetic alterations have
been implicated in the development of diffuse- and intes-
tinal-type carcinomas.47 All of the gastric carcinomas in
this study were the intestinal type, probably because all
of the carcinomas were associated with gastric adeno-
mas. Although the selected cases in our series were a
relatively homogeneous subset of tumors pathologically,
there were also remarkable intertumoral genetic hetero-
geneities. These findings indicate that many different
etiological and genetic events can result in these pheno-
typically similar gastric carcinomas. This intertumoral ge-
netic heterogeneity was also present between the gastric
adenomas, although the chromosomal changes were not
as frequent as the carcinomas. These heterogeneites of
chromosomal changes were present in the non-adjacent
pairs of gastric adenomas and carcinomas. In contrast to
the remarkable intertumoral genetic heterogeneity in our
cases, relatively clonal genetic changes were found in
adjacent pairs of gastric adenomas and carcinomas. By
CGH analysis, the clonal genetic changes were found in
all of the adjacent pairs of adenomas and carcinomas
while most of the non-adjacent pairs showed different
clonal genetic changes. The fine deletion mapping anal-
ysis on the short arm of chromosome 17 also demon-
strated the clonal genetic changes in adjacent pairs,
whereas most of the non-adjacent pairs with 17p loss did
not show the clonal changes. The common deletion areas
were found in all of the the adjacent pairs of gastric
adenomas and carcinomas, while many of the non-adja-
cent pairs showed different patterns of deletion. Addition-
ally, different microsatellite mutator phenotypes were ob-
served in some of the non-adjacent pairs of gastric
adenomas and carcinomas. These findings suggest that
different genetic changes were involved in the multiple
tumor formation. Although the sample numbers are small,
the common genetic changes within adjacent pairs of
adenomas and carcinomas, and accumulated genetic
changes in the carcinomas provide an evidence that
gastric adenomas progress to carcinomas through the
accumulation of a series of genetic alterations and sug-
gest a stepwise mode of carcinogenesis.
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